Cardio Diagnostics Holdings, Inc.
CDIO
$3.99
$0.123.10%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -50.13% | -39.51% | 105.29% | 181.10% | 1,348.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -50.13% | -39.51% | 105.29% | 181.10% | 1,348.15% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -50.13% | -39.51% | 105.29% | 181.10% | 1,348.15% |
| SG&A Expenses | -26.31% | -39.95% | 17.88% | 6.14% | 9.91% |
| Depreciation & Amortization | 285.42% | 189.06% | -22.40% | -21.74% | -18.18% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.13% | -39.79% | 15.72% | 4.15% | 8.70% |
| Operating Income | 26.01% | 39.79% | -15.51% | -3.87% | -8.24% |
| Income Before Tax | 28.76% | 49.12% | -0.08% | 11.88% | -2.19% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 28.76% | 49.12% | -0.08% | 11.88% | -2.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.76% | 49.12% | -0.08% | 11.88% | -2.19% |
| EBIT | 26.01% | 39.79% | -15.51% | -3.87% | -8.24% |
| EBITDA | 28.75% | 42.85% | -13.44% | -1.41% | -5.76% |
| EPS Basic | 67.15% | 77.52% | 52.35% | 57.81% | 47.03% |
| Normalized Basic EPS | 69.22% | 77.44% | 52.17% | 53.93% | 41.22% |
| EPS Diluted | 67.15% | 77.52% | 52.35% | 57.81% | 47.03% |
| Normalized Diluted EPS | 69.22% | 77.44% | 52.17% | 53.93% | 41.22% |
| Average Basic Shares Outstanding | 123.32% | 120.19% | 112.09% | 111.49% | 107.72% |
| Average Diluted Shares Outstanding | 123.32% | 120.19% | 112.09% | 111.49% | 107.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |